🇺🇸 Acetyl-L-Carnitine in United States

286 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 21 April 2025 – 21 April 2026
• Total reports: 286

Most-reported reactions

1. Fatigue — 48 reports (16.78%)
2. Headache — 35 reports (12.24%)
3. Diarrhoea — 31 reports (10.84%)
4. Nausea — 29 reports (10.14%)
5. Drug Ineffective — 26 reports (9.09%)
6. Pain — 25 reports (8.74%)
7. Dizziness — 24 reports (8.39%)
8. Asthenia — 23 reports (8.04%)
9. Neuropathy Peripheral — 23 reports (8.04%)
10. Insomnia — 22 reports (7.69%)

Source database →

Frequently asked questions

Is Acetyl-L-Carnitine approved in United States?

Acetyl-L-Carnitine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Acetyl-L-Carnitine in United States?

Dong-A ST Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.